Developer docs
API playgroundTry for free, no card

Search company profiles

Regulatory Pharma Net

Full company profile

uuid000yix4

Namestring
Regulatory Pharma Net
Legal namestring
Regulatory Pharma Net SRL
Company typeenum
Private
Founded yearint
1999
Descriptiontext

Regulatory Pharma Net SRL is an Italian-headquartered (Pisa) regulatory affairs and market access consultancy founded in 1999, operating as a private Società a responsabilità limitata with a nominal corporation stock of €60,000 and a headcount in the 11-50 range. The firm serves pharmaceutical, biotechnology, and medical technology companies, alongside non-EU firms entering the European market and companies targeting the US and UK, providing strategic, in-market, and executional support across the entire product life cycle. Its portfolio is organized into eight service lines: Pharmaceutical & BioTech, MedTech, EU Roadmap for Non-EU Companies, USA Specific Solutions, UK Specific Solutions, RPN Academy (training), Quality & Compliance, and the RPN AI Lab (AI innovation).

The business operates a B2B sales-led professional services model. Engagements are quote-based and tailored, initiated through structured email inquiries across five service categories (Drug Development, Regulatory Affairs, Market Access, Advertising & Promotion, Other) and direct expert consultations. Go-to-market is reinforced by content marketing via an Insights & Publications section, a corporate LinkedIn presence, and consistent participation in industry events including MAPS EMEA, DIA Europe, World EPA Congress, and ISPOR Europe and ISPOR Italy conferences. Founder and managing director Anita Falezza anchors the firm, which markets over 25 years of combined expertise and international certifications as its primary differentiator against larger CROs and pure-play consultancies.

Underlying technology is primarily human-expert delivery augmented by a nascent RPN AI Lab aimed at applying AI to regulatory and market access processes; no proprietary AI models, patents, or benchmarks are disclosed. The firm has no external investors, no parent company, no funding rounds, and no disclosed revenue, with a stated operating geography spanning Italy, Switzerland, the Netherlands, the UK, and the USA. Customers, pricing, and contract values are not publicly disclosed.

Short descriptiontext

Regulatory Pharma Net is an Italian regulatory affairs and market access consultancy serving pharmaceutical, biotech, and MedTech companies across the EU, US, and UK via eight service lines including an AI lab and training academy.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersPisa, Italy
HQ citystring
Pisa
HQ countrystring
Italy
HQ regionstring
Europe
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
regulatory affairs consulting, market access strategy, pharmaceutical consulting, medical device regulations, drug development services
Industry1 code
PRIMARYHLAGAKAC
Regulatory Operations & Publishing (eCTD, RIM, Submission Management)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Regulatory Affairs, Quality & Compliance Services (GxP)
Product category
Pharmaceutical Regulatory Affairs Consulting
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Regulatory Affairs & Market Access Consulting
TypeProfessional Services
Description

Professional consulting services providing end-to-end support for pharmaceutical and life science companies throughout the product lifecycle. Services include regulatory affairs strategy, market access planning, and executional expertise across international markets.

rpngroup.com
Marketing channels3 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Technology or R&D, Marketing or Sales, Others
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

Regulatory Pharma Net is a consulting firm that delivers regulatory affairs and market access services to pharmaceutical, biotechnology, and medical device companies. It sells end-to-end strategic, in-market, and executional expertise across the entire product life cycle and across international markets (EU, USA, UK), with a one-stop-shop portfolio of eight service lines spanning pharma/biotech, medtech, regional market entry, training, quality & compliance, and an AI innovation lab.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

Regulatory Pharma Net operates as a service-based consultancy offering an integrated portfolio of regulatory affairs and market access solutions for the pharmaceutical, biotech, and medtech industries. The portfolio is organized into eight distinct service offerings: Pharmaceutical & BioTech Services, Medtech Services, EU Roadmap for Non-EU Companies, USA Specific Solutions, UK Specific Solutions, RPN Academy (training), Quality & Compliance, and RPN AI Lab (AI innovation). These services are designed to work together seamlessly, providing end-to-end support throughout the entire product life cycle and across international markets, with over 25 years of combined expertise.

Product and service1 record
1Pharmaceutical & BioTech Services
Scale indicator2 records

Each record includes

Type, Value, Description, Source

Partnership4 partners
Strategic tierMinorTypeOthersAnnounced on2026-01-01
Description

RPN participates as an attendee/exhibitor at the MAPS EMEA Annual Meeting 2026 in Zurich, Switzerland. This represents professional association membership and event participation in the medical affairs community.

2DIA Europe
Strategic tierMinorTypeOthersAnnounced on2026-01-01
Description

RPN participates at DIA Europe 2026 conference in Rotterdam. DIA is a global organization providing education and networking for health professionals involved in the discovery, development, and lifecycle management of healthcare products.

rpngroup.com
3World EPA Congress
Strategic tierMinorTypeOthersAnnounced on2026-01-01
Description

RPN participates at the World EPA Congress 2026 in Amsterdam, focusing on health economics and outcomes research, pricing, and market access.

rpngroup.com
Strategic tierMinorTypeOthersAnnounced on2025-01-01
Description

RPN participates in ISPOR events including ISPOR Europe 2025 in Glasgow and the ISPOR Italy Rome Chapter 2025 conference, demonstrating involvement in pharmacoeconomics and outcomes research community.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

European regulatory affairs and market access advisory serving drug and device developers, directly comparable to RPN's strategic regulatory consulting.

TypeDirect peer
Description

Boutique-to-mid European provider of regulatory affairs, pharmacovigilance, and quality/compliance services, similar in scope and client base to RPN.

TypeDirect peer
Description

Regulatory and product development consultancy guiding pharma, biotech, and medtech through EU and US approval and market access, aligning with RPN's advisory positioning.

4Diamond Pharma Services
TypeDirect peer
Description

European regulatory affairs and market access consultancy supporting product lifecycle and EU market entry, closely matching RPN's service mix.

TypeBroad incumbent
Description

Global provider of regulatory affairs, pharmacovigilance, and market access services to pharma and medtech; directly overlaps with RPN's core offering but at far larger scale and footprint.

TypeEmerging player
Description

UK-based product development and regulatory affairs consultancy for pharma and biotech, comparable to RPN's lifecycle advisory and UK-specific solutions.

7Real Regulatory
TypeRegional player
Description

Ireland-based regulatory affairs and quality consultancy for pharma and medtech serving European market access, similar niche to RPN but focused on a different geography.

TypeDirect peer
Description

Specialist medtech regulatory and quality consultancy covering EU MDR and US FDA, overlapping with RPN's Medtech and Quality & Compliance service lines.

TypeDirect peer
Description

European regulatory affairs, market access, and compliance consultancy for life sciences companies, closely comparable to RPN's integrated end-to-end service portfolio.

TypeDirect peer
Description

Specialized regulatory affairs and compliance services firm serving pharma, biotech, and medtech across EU/US/UK, mirroring RPN's multi-jurisdiction consulting model.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment5 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI capability1 record

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature1 record

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Regulatory Pharma Net

Pharmaceutical Regulatory Affairs Consultingregulatorypharmanet.com

Regulatory Pharma Net is an Italian regulatory affairs and market access consultancy serving pharmaceutical, biotech, and MedTech companies across the EU, US, and UK via eight service lines including an AI lab and training academy.

What Regulatory Pharma Net does

Regulatory Pharma Net SRL is an Italian-headquartered (Pisa) regulatory affairs and market access consultancy founded in 1999, operating as a private Società a responsabilità limitata with a nominal corporation stock of €60,000 and a headcount in the 11-50 range. The firm serves pharmaceutical, biotechnology, and medical technology companies, alongside non-EU firms entering the European market and companies targeting the US and UK, providing strategic, in-market, and executional support across the entire product life cycle. Its portfolio is organized into eight service lines: Pharmaceutical & BioTech, MedTech, EU Roadmap for Non-EU Companies, USA Specific Solutions, UK Specific Solutions, RPN Academy (training), Quality & Compliance, and the RPN AI Lab (AI innovation).

The business operates a B2B sales-led professional services model. Engagements are quote-based and tailored, initiated through structured email inquiries across five service categories (Drug Development, Regulatory Affairs, Market Access, Advertising & Promotion, Other) and direct expert consultations. Go-to-market is reinforced by content marketing via an Insights & Publications section, a corporate LinkedIn presence, and consistent participation in industry events including MAPS EMEA, DIA Europe, World EPA Congress, and ISPOR Europe and ISPOR Italy conferences. Founder and managing director Anita Falezza anchors the firm, which markets over 25 years of combined expertise and international certifications as its primary differentiator against larger CROs and pure-play consultancies.

Underlying technology is primarily human-expert delivery augmented by a nascent RPN AI Lab aimed at applying AI to regulatory and market access processes; no proprietary AI models, patents, or benchmarks are disclosed. The firm has no external investors, no parent company, no funding rounds, and no disclosed revenue, with a stated operating geography spanning Italy, Switzerland, the Netherlands, the UK, and the USA. Customers, pricing, and contract values are not publicly disclosed.

Regulatory Pharma Net firmographics

Firmographics
Name
Regulatory Pharma Net
Legal name
Regulatory Pharma Net SRL
Website
https://regulatorypharmanet.com
Company type
Private
Founded year
1999
Operating status
Operating
Headcount range
11–50 employees
Short description
Regulatory Pharma Net is an Italian regulatory affairs and market access consultancy serving pharmaceutical, biotech, and MedTech companies across the EU, US, and UK via eight service lines including an AI lab and training academy.
Ownership category
akta.pro rank

Regulatory Pharma Net industry classification

Industry
Product category
Pharmaceutical Regulatory Affairs Consulting
akta.pro industry
PRIMARYHLAGAKAC
Regulatory Operations & Publishing (eCTD, RIM, Submission Management)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Regulatory Affairs, Quality & Compliance Services (GxP)

Keywords

  • Regulatory affairs consulting
  • Market access strategy
  • Pharmaceutical consulting
  • Medical device regulations
  • Drug development services

Where Regulatory Pharma Net is headquartered

Location

Headquarters

HQ city
Pisa
HQ country
Italy
HQ region
Europe

Offices1 record

Markets served

Regulatory Pharma Net business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Technology or R&D, Marketing or Sales, Others

Revenue model

  1. Regulatory Affairs & Market Access Consulting: Professional consulting services providing end-to-end support for pharmaceutical and life science companies throughout the product lifecycle. Services include regulatory affairs strategy, market access planning, and executional expertise across international markets.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels3 records

Regulatory Pharma Net product offering

Product offering

Core offering

Regulatory Pharma Net is a consulting firm that delivers regulatory affairs and market access services to pharmaceutical, biotechnology, and medical device companies. It sells end-to-end strategic, in-market, and executional expertise across the entire product life cycle and across international markets (EU, USA, UK), with a one-stop-shop portfolio of eight service lines spanning pharma/biotech, medtech, regional market entry, training, quality & compliance, and an AI innovation lab.

Product overview

Regulatory Pharma Net operates as a service-based consultancy offering an integrated portfolio of regulatory affairs and market access solutions for the pharmaceutical, biotech, and medtech industries. The portfolio is organized into eight distinct service offerings: Pharmaceutical & BioTech Services, Medtech Services, EU Roadmap for Non-EU Companies, USA Specific Solutions, UK Specific Solutions, RPN Academy (training), Quality & Compliance, and RPN AI Lab (AI innovation). These services are designed to work together seamlessly, providing end-to-end support throughout the entire product life cycle and across international markets, with over 25 years of combined expertise.

Differentiator

Problem solved

Functional benefit

Products and services

  • Pharmaceutical & BioTech Services

Companies that use Regulatory Pharma Net

Customer profile

Segments5 records

Ideal customer profiles1 record

Regulatory Pharma Net technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability1 record

Feature1 record

Regulatory Pharma Net partnerships and signals

Strategic signal

Partnerships

Four partnerships are on record, tiered minor.

  • Medical Affairs Professional Society (MAPS)minorOthers · 1 January 2026RPN participates as an attendee/exhibitor at the MAPS EMEA Annual Meeting 2026 in Zurich, Switzerland. This represents professional association membership and event participation in the medical affairs community.
  • DIA EuropeminorOthers · 1 January 2026RPN participates at DIA Europe 2026 conference in Rotterdam. DIA is a global organization providing education and networking for health professionals involved in the discovery, development, and lifecycle management of healthcare products.
  • World EPA CongressminorOthers · 1 January 2026RPN participates at the World EPA Congress 2026 in Amsterdam, focusing on health economics and outcomes research, pricing, and market access.
  • ISPOR (International Society for Pharmacoeconomics and Outcomes Research)minorOthers · 1 January 2025RPN participates in ISPOR events including ISPOR Europe 2025 in Glasgow and the ISPOR Italy Rome Chapter 2025 conference, demonstrating involvement in pharmacoeconomics and outcomes research community.

Scale indicators2 records

Recent moves6 records

Expansion highlights6 records

Regulatory Pharma Net competitors and assessment

Company assessment

Direct peers

  • NDA Group: European regulatory affairs and market access advisory serving drug and device developers, directly comparable to RPN's strategic regulatory consulting.
  • Arriello: Boutique-to-mid European provider of regulatory affairs, pharmacovigilance, and quality/compliance services, similar in scope and client base to RPN.
  • Voisin Consulting Life Sciences: Regulatory and product development consultancy guiding pharma, biotech, and medtech through EU and US approval and market access, aligning with RPN's advisory positioning.
  • Diamond Pharma Services: European regulatory affairs and market access consultancy supporting product lifecycle and EU market entry, closely matching RPN's service mix.
  • Qserve Group: Specialist medtech regulatory and quality consultancy covering EU MDR and US FDA, overlapping with RPN's Medtech and Quality & Compliance service lines.
  • ProductLife Group: European regulatory affairs, market access, and compliance consultancy for life sciences companies, closely comparable to RPN's integrated end-to-end service portfolio.
  • Freyr Solutions: Specialized regulatory affairs and compliance services firm serving pharma, biotech, and medtech across EU/US/UK, mirroring RPN's multi-jurisdiction consulting model.

Broad incumbents

  • PharmaLex: Global provider of regulatory affairs, pharmacovigilance, and market access services to pharma and medtech; directly overlaps with RPN's core offering but at far larger scale and footprint.

Emerging players

  • Boyds: UK-based product development and regulatory affairs consultancy for pharma and biotech, comparable to RPN's lifecycle advisory and UK-specific solutions.

Regional players

  • Real Regulatory: Ireland-based regulatory affairs and quality consultancy for pharma and medtech serving European market access, similar niche to RPN but focused on a different geography.

Market position

Strengths5 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

Regulatory Pharma Net social profiles

Digital presence

Regulatory Pharma Net financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Regulatory Pharma Net leadership team

Management profile

Number of profiles

Profiles1 record

Regulatory Pharma Net funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Regulatory Pharma Net M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Regulatory Pharma Net

What does Regulatory Pharma Net do?

Regulatory Pharma Net is a consulting firm that delivers regulatory affairs and market access services to pharmaceutical, biotechnology, and medical device companies. It sells end-to-end strategic, in-market, and executional expertise across the entire product life cycle and across international markets (EU, USA, UK), with a one-stop-shop portfolio of eight service lines spanning pharma/biotech, medtech, regional market entry, training, quality & compliance, and an AI innovation lab.

Is Regulatory Pharma Net a public or private company?

Regulatory Pharma Net is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Regulatory Pharma Net founded?

Regulatory Pharma Net was founded in 1999. It employs 11 to 50 people.

Where is Regulatory Pharma Net based?

Regulatory Pharma Net is headquartered in Pisa, Italy, in the Europe region.

How does Regulatory Pharma Net make money?

One revenue line is on record: regulatory Affairs & Market Access Consulting.

Who are Regulatory Pharma Net's main competitors?

Direct peers on record are NDA Group, Arriello, Voisin Consulting Life Sciences, Diamond Pharma Services, Qserve Group, ProductLife Group and Freyr Solutions. PharmaLex is listed as a broad incumbent. Boyds is listed as an emerging player. Real Regulatory is listed as a regional player.

Does Regulatory Pharma Net have an API?

No public API is recorded for Regulatory Pharma Net.

What industry is Regulatory Pharma Net in?

Regulatory Pharma Net's product category is Pharmaceutical Regulatory Affairs Consulting. Its primary akta.pro industry code is HLAGAKAC, Regulatory Operations & Publishing (eCTD, RIM, Submission Management).

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales